BR0215070A - Métodos de tratamento de infecções bacterianas em cães e gatos - Google Patents

Métodos de tratamento de infecções bacterianas em cães e gatos

Info

Publication number
BR0215070A
BR0215070A BR0215070-0A BR0215070A BR0215070A BR 0215070 A BR0215070 A BR 0215070A BR 0215070 A BR0215070 A BR 0215070A BR 0215070 A BR0215070 A BR 0215070A
Authority
BR
Brazil
Prior art keywords
dogs
cats
bacterial infections
methods
treating bacterial
Prior art date
Application number
BR0215070-0A
Other languages
English (en)
Inventor
Simon Edward Blanchflower
Brian Scott Bronk
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0130694.3A external-priority patent/GB0130694D0/en
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of BR0215070A publication Critical patent/BR0215070A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

"MéTODOS DE TRATAMENTO DE INFECçõES BACTERIANAS EM CãES E GATOS". A invenção aqui descrita relaciona-se com o tratamento de uma gama de infecções bacterianas em animais de companhia, em particular gatos e cães, com um derivado b-lactama, composto de Fórmula I: A invenção também é dirigida a composições farmacêuticas de um composto de Fórmula I.
BR0215070-0A 2001-12-21 2002-11-13 Métodos de tratamento de infecções bacterianas em cães e gatos BR0215070A (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB0130694.3A GB0130694D0 (en) 2001-12-21 2001-12-21 Treatment
US35996102P 2002-02-27 2002-02-27
US39893302P 2002-07-26 2002-07-26
PCT/IB2002/004741 WO2003053522A1 (en) 2001-12-21 2002-11-13 Methods of treating bacterial infections in dogs and cats

Publications (1)

Publication Number Publication Date
BR0215070A true BR0215070A (pt) 2004-11-09

Family

ID=27256361

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0215070-0A BR0215070A (pt) 2001-12-21 2002-11-13 Métodos de tratamento de infecções bacterianas em cães e gatos

Country Status (12)

Country Link
EP (1) EP1455900A1 (pt)
JP (1) JP2005524611A (pt)
CN (1) CN1606463A (pt)
AR (1) AR037594A1 (pt)
AU (1) AU2002348985A1 (pt)
BR (1) BR0215070A (pt)
CA (1) CA2470995A1 (pt)
IL (1) IL162103A0 (pt)
NO (1) NO20043008L (pt)
PL (1) PL370624A1 (pt)
TW (1) TW200301126A (pt)
WO (1) WO2003053522A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1740214B1 (en) * 2004-04-22 2007-10-03 Pfizer Products Incorporated Method of stabilizing disordered cefovecin sodium salt

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0395219B1 (en) * 1989-03-30 1998-09-30 Pfizer Inc. Cephalosporins and their homologues, process for their preparation and pharmaceutical compositions
GB9424847D0 (en) * 1994-12-09 1995-02-08 Smithkline Beecham Plc Novel process
GB2300856A (en) * 1995-05-16 1996-11-20 Pfizer Ltd Beta-lactam preparation

Also Published As

Publication number Publication date
TW200301126A (en) 2003-07-01
IL162103A0 (en) 2005-11-20
AR037594A1 (es) 2004-11-17
CN1606463A (zh) 2005-04-13
EP1455900A1 (en) 2004-09-15
NO20043008L (no) 2004-09-01
AU2002348985A1 (en) 2003-07-09
CA2470995A1 (en) 2003-07-03
PL370624A1 (en) 2005-05-30
JP2005524611A (ja) 2005-08-18
WO2003053522A1 (en) 2003-07-03

Similar Documents

Publication Publication Date Title
CY1108367T1 (el) Φαινυλο-καρβοξαμιδικες ενωσεις χρησιμες για την αντιμετωπιση πονου
BR0214736A (pt) Composto e seus sais farmaceuticamente aceitáveis, composição farmacêutica e método de tratar seres humanos ou animais que sofrem de doenças ou condições
AR037595A1 (es) Metodos de tratamiento y formulaciones de cefalosporina
BRPI0411241A (pt) agentes terapêuticos úteis para o tratamento de dor
TR200001330T2 (tr) Oksazolidinon türevleri ve farmasötik terkipler
HRP20050517B1 (hr) N-sulfonil-4-metilenamino-3-hidroksi-2-piridoni kao antimikrobni lijekovi
PT911331E (pt) Compostos de dibenzoxazepina substituidos composicoes farmaceuticas e metodos de utilizacao
CY1119257T1 (el) Θεραπεια του νευροπαθητικου πονου με ανταγωνιστες υποδοχεα δεξτρομεθορφανης n-meθυλ-d-ασπαρτικων (nmda)
BR0015722A (pt) Uso de derivados de pleuromutilina para tratamento transdérmico de doenças bacterianas
CA2288341A1 (en) Erythropoietin in the treatment of domestic and livestock animals for anemia
BR0215070A (pt) Métodos de tratamento de infecções bacterianas em cães e gatos
BR9807187A (pt) Composto de carbapenem, seu uso e composto intermediário para o mesmo
DE69827814D1 (de) 8a-AZALIDEN ALS ANTIMIKROBIELLE AGENTEN
ATE284397T1 (de) 5-(alkylidene-cycloalkyl)- und 5-(alkylidene- heterocyclyl)-pyrazole
BR0204547A (pt) Pirazóis de 5-heteroátomo-substituìdo
DE69810474D1 (de) Medizinische zusammensetzungen gegen helicobacter pylori
BR0308734A (pt) Composto, composição farmacêutica, uso do composto, e, método para prevenir ou tratar infecção
GB0003234D0 (en) Method of treatment
BR0204551A (pt) S-heterociclo-pirazóis
BR0007491A (pt) Uso de 3-isoxazolidinonas e ácidos hidroxilâmicospara o tratamento de infecções
EA200100768A1 (ru) Применение 3-изоксазолидинонов и гидроксиаминокислот для лечения инфекций
ES2159087T3 (es) Oxindoles sustituidos con adamantilo como agentes farmaceuticos.
BR0204429A (pt) Heterociclo-alquilsulfonil-pirazóis
TH36001A (th) สารประกอบคาร์บาเพเนม การใช้ประโยชน์ของมัน และสารประกอบมัธยันตร์ของมัน
BR9905749A (pt) Eritropoietina no tratamento de anemia em animais domésticos e animais de criação

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A4A, 5A,6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2034 DE 29/12/2009.

B15K Others concerning applications: alteration of classification

Ipc: A61K 31/545 (2006.01), A61P 31/04 (2006.01)